Institutional investors hold a majority ownership of OREX through the 79.15% of the outstanding shares that they control. This interest is also higher than at almost any other company in the Biotechnology industry. Last, during the quarter ended September 2014, these large investors purchased a net $8.8 million shares.
Mutual fund holders
Largest Quarterly Institutional Transactions
Latest Institutional Activity
FORTALEZA ASSET MANAGEMENT, INC. Bought 85.9 Thousand shares of Orexigen Therapeutics Inc